Effect of Social Media Support and Financial Incentives on PrEP Adherence

Overview

The purpose of this study is to determine if social media support and financial incentives improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24 living in the Washington, DC area who are at high risk for HIV acquisition.

Full Title of Study: “The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in Young MSM of Color in Washington, DC”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 15, 2020

Interventions

  • Behavioral: Financial Incentive
    • Participants will receive a $50 gift card at 3- and 6- month follow-up visits.
  • Behavioral: Social Media Group
    • Participants will be invited to a study Facebook group which will have links to PrEP information and provide a forum for participants to ask questions and communicate their experience with PrEP

Arms, Groups and Cohorts

  • Experimental: Financial Incentive
    • Provided financial incentive at 3-month and 6-month follow-up visits
  • Experimental: Social Media Group
    • Provided social media support through a facebook group for 6 months
  • No Intervention: Control
    • No intervention

Clinical Trial Outcome Measures

Primary Measures

  • Adherence To Truvada
    • Time Frame: 6 months
    • Level of Truvada drug levels inside red blood cells (performed by dried blood spots)

Secondary Measures

  • New Cases of HIV
    • Time Frame: 6 months
    • Number of reactive HIV rapid and 4th generation tests
  • Incidence of STIs
    • Time Frame: 6 months
    • Positive RPR, oropharyngeal/rectal/penile chlamydia and gonorrhea during study

Participating in This Clinical Trial

Inclusion Criteria

  • Male assigned at birth (regardless of current gender identity) – Age 18-24 – Black/African American, Latino or Asian – HIV negative – History of unprotected anal sex with a man in the last 6 months – Living within the DC metropolitan statistical area and anticipate remaining within the DC area for the next 6 months – Not enrolled in any other HIV prevention trial – Interested in taking PrEP – Not a current PrEP user and have not taken PrEP in the last 30 days – Able to provide informed consent Exclusion Criteria:

  • Female sex at birth – Age younger than 18 or older than 24 – Caucasian – HIV positive – Actively taking PrEP or having taken PrEP within 30 days of enrollment – Chronic hepatitis B infection – Known renal insufficiency – On probation or parole – Any other conditions that the Principal Investigator may consider a contraindication to enrolling in the study

Gender Eligibility: Male

male at birth (regardless of current gender identity)

Minimum Age: 18 Years

Maximum Age: 24 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • George Washington University
  • Collaborator
    • National Institute of Allergy and Infectious Diseases (NIAID)
  • Provider of Information About this Clinical Study
    • Principal Investigator: Marc O. Siegel, Principal Investigator – George Washington University
  • Overall Official(s)
    • Marc Siegel, MD, Principal Investigator, The GW Medical Faculty Associates

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.